Zhejiang Starry Pharmaceutical Co.,Ltd. (SHA:603520)

China flag China · Delayed Price · Currency is CNY
10.38
+0.03 (0.29%)
Feb 4, 2026, 3:00 PM CST
26.43%
Market Cap4.55B +19.3%
Revenue (ttm)2.39B +0.9%
Net Income-29.25M
EPS-0.08
Shares Out438.41M
PE Ration/a
Forward PE61.06
Dividend0.20 (1.93%)
Ex-Dividend DateSep 12, 2025
Volume7,115,260
Average Volume12,179,488
Open10.37
Previous Close10.35
Day's Range10.26 - 10.49
52-Week Range7.44 - 12.82
Beta0.65
RSI48.92
Earnings DateApr 30, 2026

About SHA:603520

Zhejiang Starry Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical raw materials in China and internationally. It operates through Contrast Agent Series, Quinolone Series, CMO/CDMO, and Others segments. The company offers preparation products comprising iohexol, iopamidol, iodixanol, iomeprol, ioversol, and gadobenate dimeglumine injections; contrast agent APIs and intermediates consisting of iohexol, iopamidol, iodixanol, ioversol, iopromide, iomeprol, gadobenat... [Read more]

Sector Healthcare
Founded 1997
Employees 1,754
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603520
Full Company Profile

Financial Performance

Financial Statements